5 January 2021
New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.
Researchers at the University of Oxford and University College London investigated 542 older adults who received two measurements of aortic stiffness, at 64 years old and 68 years old. Subsequent cognitive tests and brain magnetic resonance imaging (MRI) scans assessed the size, connections and blood supply of different brain regions.
The body’s largest artery (the aorta) gets stiffer with age, and the study found that faster aortic stiffening in mid-life to older age was linked to markers of poorer brain health, for example:
- Lower brain blood supply
- Reduced structural connectivity between different brain regions
- Worse memory
Medical interventions and changes of lifestyle made earlier in the lifespan could help to slow down arterial stiffening. In an ageing society where we expect a near tripling in the number of people living with dementia by 2050, identifying ways to prevent or delay its onset could have significant societal and economic impact.
Dr Sana Suri, Alzheimer’s Society Research Fellow at the Department of Psychiatry, University of Oxford, said, “Our study links heart health with brain health, and gives us insights into the potential of reducing aortic stiffening to help maintain brain health in older ages. Reduced connectivity between different brain regions is an early marker of neurodegenerative diseases such as Alzheimer's disease, and preventing these changes by reducing or slowing down the stiffening of our body's large blood vessels may be one way to maintain brain health and memory as we grow older.”
This study shows the importance of interdisciplinary work in this field and stresses the benefits of studying the brain in conjunction with other organ systems. Arteries stiffen faster if someone has pre-existing heart diseases, high blood pressure, diabetes and other vascular diseases. Arterial stiffening is also progressively faster with long-term exposure to poor health behaviours and lifestyle risk factors, such as smoking or poor diets. It is possible to reduce arterial stiffening by medical treatments or lifestyle interventions, such as modifying the diet and exercising.
Dr Scott Chiesa, Research Associate at the UCL Institute of Cardiovascular Science, said, “With no cure for dementia, there is an increased focus on understanding how to prevent or delay its onset. Importantly, our study helps us understand when in the lifespan it will be best to target and improve cardiovascular health to benefit the brain.”
Dr Richard Oakley, Head of Research at Alzheimer’s Society, which funded the study, said, “Dementia devastates lives, and with the number of people with dementia set to rise to 1 million by 2025 and more families affected than ever before, reducing our risk has never been more important. This Alzheimer’s Society funded study didn’t look for a link between heart health and dementia directly, but it has shed important light on a connection between the health of our blood vessels and changes in the brain that indicate brain health.
“We know that what’s good for your heart is good for your head, and it’s exciting to see research that explores this link in more detail. But we need even more research to understand the impact of heart health on brain health as we age, and how that affects our own dementia risk. Alzheimer’s Society is committed to funding research into dementia prevention as well as research into a cure. But coronavirus has hit us hard, so it’s vital the Government honours its commitment to double dementia research spending to continue research like this.”
Participants in this study were part of the Imaging subset of the Whitehall II Study, a cohort of British civil service members who have received clinical follow-ups for over 30 years. Participants were predominantly white males and were selected if they had no clinical diagnosis of dementia. Further research in diverse samples and people with more advanced cognitive deficits will be needed to confirm these findings in a wider population.
The Whitehall II Study and the Whitehall II Imaging Sub-study are funded by grants from the UK Medical Research Council, British Heart Foundation, and US National Institute on Aging.
Notes to editors:
For further information, please contact: Gen Juillet, Media Relations Manager, University of Oxford, firstname.lastname@example.org
To see the full paper, Associations between arterial stiffening and brain structure, perfusion and cognition in the Whitehall II Imaging Sub-study: A retrospective cohort study, https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003467
For information about the Whitehall II Study https://www.ucl.ac.uk/epidemiology-health-care/research/epidemiology-and-public-health/research/whitehall-ii
About the University of Oxford
Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the fifth year running, and at the heart of this success is our ground-breaking research and innovation. Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions.
The University Department of Psychiatry’s mission is to conduct world-class research, teach psychiatry to medical students, develop future researchers in a graduate programme, teach doctors in training, promote excellence in clinical practice, and develop and provide innovative clinical services. It supports research in four key areas: neurobiology, psychological treatments, developmental psychiatry and social psychiatry. The Department is committed to the translation of scientific discovery into benefits for patients. www.psych.ox.ac.uk
Funding for the University of Oxford’s coronavirus research is crucial to the development of a vaccine and the subsequent delivery of effective drugs to combat this new virus. Unprecedented speed, scope and ambition is required. Please make a gift. Any gift made will help contribute to the fight against coronavirus.
About the Alzheimer's Society
Alzheimer's Society is the UK's leading dementia charity. We provide information and support, fund research, campaign to improve care and create lasting change for people affected by dementia in England, Wales and Northern Ireland. Dementia devastates lives. Alzheimer’s Society research shows that 850,000 people in the UK have a form of dementia. Dementia deaths are rising year on year and 225,000 will develop dementia this year - that’s one every three minutes. Dementia costs the UK economy over £26 billion per year. This is the equivalent of more than £30,000 per person with dementia.
Alzheimer’s Society funds research into the cause, care, cure and prevention of all types of dementia, committing to spend at least £100 million on research over the next decade, and is a founding partner of the UK Dementia Research Institute. Until the day we find a cure, Alzheimer's Society will be here for anyone affected by dementia - wherever they are, whatever they're going through. Everything we do is informed and inspired by them.
Let's take on dementia together. Volunteer. Donate. Campaign for change. Whatever you do, unite with us against dementia. Alzheimer’s Society relies on voluntary donations to continue our vital work. You can donate now by calling 0330 333 0804 or visiting alzheimers.org.uk.
Dr Sana Suri was funded by the UK Alzheimer’s Society.